Literature DB >> 11793714

Applying data mining techniques to the mapping of complex disease genes.

W A Czika1, B S Weir, S R Edwards, R W Thompson, D M Nielsen, J C Brocklebank, C Zinkus, E R Martin, K E Hobler.   

Abstract

The simulated sequence data for the Genetic Analysis Workshop 12 were analyzed using data mining techniques provided by SAS ENTERPRISE MINER Release 4.0 in addition to traditional statistical tests for linkage and association of genetic markers with disease status. We examined two ways of combining these approaches to make use of the covariate data along with the genotypic data. The result of incorporating data mining techniques with more classical methods is an improvement in the analysis, both by correctly classifying the affection status of more individuals and by locating more single nucleotide polymorphisms related to the disease, relative to analyses that use classical methods alone.

Mesh:

Substances:

Year:  2001        PMID: 11793714     DOI: 10.1002/gepi.2001.21.s1.s435

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  4 in total

1.  Generalized T2 test for genome association studies.

Authors:  Momiao Xiong; Jinying Zhao; Eric Boerwinkle
Journal:  Am J Hum Genet       Date:  2002-03-29       Impact factor: 11.025

2.  Automated detection of informative combined effects in genetic association studies of complex traits.

Authors:  Nadia Tahri-Daizadeh; David-Alexandre Tregouet; Viviane Nicaud; Nicolas Manuel; François Cambien; Laurence Tiret
Journal:  Genome Res       Date:  2003-08       Impact factor: 9.043

Review 3.  Large recursive partitioning analysis of complex disease pharmacogenetic studies. II. Statistical considerations.

Authors:  Dmitri V Zaykin; S Stanley Young
Journal:  Pharmacogenomics       Date:  2005-01       Impact factor: 2.533

Review 4.  Genetic Signatures of Asthma Exacerbation.

Authors:  Heung Woo Park; Kelan G Tantisira
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.